Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Amuchina

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Exit-site infection (ESI), tunnel infection and associated peritonitis are major causes of morbidity and catheter loss in chronic… Expand
2007
2007
Although, decreasing in incidence with the disconnection systems, the first complication is still peritonitis in patients with… Expand
2005
2005
In a previous communication, we demonstrated that, in the prevention of exit-site infection (ESI) in children, the cleansing… Expand
2004
2004
The aim of this work was to verify the in vitro virucidal activity of VIRKON No Foam (VIRKON NF) against the HBV DNA, notoriously… Expand
  • table 1
  • figure 1
  • figure 2
1998
1998
The goal of this study was to compare the safety and efficacy of Amuchina 50% solution versus that of povidone-iodine 10… Expand
1994
1994
The frequency and characteristics of episodes of accidental symptomatic introduction of Amuchina in CAPD patients has been… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1993
1993
The purpose of this study was to evaluate the In vltro and in vivo efficacy of a new connection system for continuous ambulatory… Expand
Highly Cited
1989
Highly Cited
1989
sixty-one new continuous ambulatory peritoneal dialysis (CAPD) patients were allocated to a Y connector disinfectant (Amuchina… Expand
1989
1989
Among 63 patients (pts) on HPD 26 (41.7%) had need of a partner (PN) in conducting dialysis. In most cases the role of a partner… Expand
1988
1988
Continuous ambulatory peritoneal dialysis (CAPD) is an effective long-term treatment for renal failure. Sclerosing encapsulating… Expand